daptomycin
Generic: daptomycin
Labeler: sagent pharmaceuticalsDrug Facts
Product Profile
Brand Name
daptomycin
Generic Name
daptomycin
Labeler
sagent pharmaceuticals
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
daptomycin 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
25021-174
Product ID
25021-174_a3f62ffc-f089-4f4c-bad1-99f60f1d88b0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207104
Listing Expiration
2026-12-31
Marketing Start
2019-11-15
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
25021174
Hyphenated Format
25021-174
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
daptomycin (source: ndc)
Generic Name
daptomycin (source: ndc)
Application Number
ANDA207104 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 1 VIAL in 1 CARTON (25021-174-15) / 10 mL in 1 VIAL
- 10 VIAL in 1 CARTON (25021-174-16) / 10 mL in 1 VIAL
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a3f62ffc-f089-4f4c-bad1-99f60f1d88b0", "openfda": {"nui": ["N0000175509", "M0519359"], "unii": ["NWQ5N31VKK"], "rxcui": ["403920"], "spl_set_id": ["f4ad8613-f25e-4b82-9621-cc5ff9525d3e"], "pharm_class_cs": ["Lipopeptides [CS]"], "pharm_class_epc": ["Lipopeptide Antibacterial [EPC]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-174-15) / 10 mL in 1 VIAL", "package_ndc": "25021-174-15", "marketing_start_date": "20191115"}, {"sample": false, "description": "10 VIAL in 1 CARTON (25021-174-16) / 10 mL in 1 VIAL", "package_ndc": "25021-174-16", "marketing_start_date": "20191115"}], "brand_name": "daptomycin", "product_id": "25021-174_a3f62ffc-f089-4f4c-bad1-99f60f1d88b0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Lipopeptide Antibacterial [EPC]", "Lipopeptides [CS]"], "product_ndc": "25021-174", "generic_name": "daptomycin", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "daptomycin", "active_ingredients": [{"name": "DAPTOMYCIN", "strength": "50 mg/mL"}], "application_number": "ANDA207104", "marketing_category": "ANDA", "marketing_start_date": "20191115", "listing_expiration_date": "20261231"}